围手术期糖皮质激素医-药专家共识

2021-06-21 广东省药学会 今日药学.

外科手术创伤可刺激机体产生一系列应激反应,引起组织损伤、缺血缺氧、炎症反应等。糖皮质激素(glucocorticoids,GCs)作为机体应激反应最重要的调节激素,在应激状态下分泌会增加。围手术期加速

中文标题:

围手术期糖皮质激素医-药专家共识

发布机构:

广东省药学会

发布日期:

2021-06-21

简要介绍:

外科手术创伤可刺激机体产生一系列应激反应,引起组织损伤、缺血缺氧、炎症反应等。糖皮质激素(glucocorticoids,GCs)作为机体应激反应最重要的调节激素,在应激状态下分泌会增加。围手术期加速康复外科(enhanced recovery after surgery,ERAS)的主要目的是优化围手术期的处理措施,降低手术应激反应,减少术后并发症,缩短住院时间,促进患者快速康复。在某些特定情况下给予机体外源性GCs是ERAS主要治疗措施之一。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=围手术期糖皮质激素医_药专家共识_广东省药学会.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f1e781c002128e51, title=围手术期糖皮质激素医-药专家共识, enTitle=, guiderFrom=今日药学., authorId=0, author=, summary=外科手术创伤可刺激机体产生一系列应激反应,引起组织损伤、缺血缺氧、炎症反应等。糖皮质激素(glucocorticoids,GCs)作为机体应激反应最重要的调节激素,在应激状态下分泌会增加。围手术期加速, cover=https://img.medsci.cn/2021715/1626283787644_2020535.jpg, journalId=0, articlesId=null, associationId=1082, associationName=广东省药学会, associationIntro=广东省药学会前身为1945年成立的广州药师公会,1951年成为中国药学会广州分会。1958年在原有基础上扩大组织,成立中国药学会广东分会,负责组织全省药学科技工作者的相关活动。1985年起,中国药学会广东分会一直挂靠在广东省食品药品监督管理局(省医药管理局)。1991年,按民政部门文件要求更名为广东省药学会。, copyright=0, guiderPublishedTime=Mon Jun 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">外科手术创伤可刺激机体产生一系列应激反应,引起组织损伤、缺血缺氧、炎症反应等。糖皮质激素(glucocorticoids,GCs)作为机体应激反应最重要的调节激素,在应激状态下分泌会增加。围手术期加速康复外科(enhanced recovery after surgery,ERAS)的主要目的是优化围手术期的处理措施,降低手术应激反应,减少术后并发症,缩短住院时间,促进患者快速康复</span><span style="color: #666666;">。在某些特定情况下给予机体外源性GCs是ERAS主要治疗措施之一。&nbsp;</span></p>, tagList=[TagDto(tagId=541, tagName=糖皮质激素), TagDto(tagId=800, tagName=围手术期)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=541, guiderKeyword=糖皮质激素, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7479, appHits=162, showAppHits=0, pcHits=612, showPcHits=7317, likes=0, shares=16, comments=14, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-06-21, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:29:53 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 22:10:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=围手术期糖皮质激素医_药专家共识_广东省药学会.pdf)])
围手术期糖皮质激素医_药专家共识_广东省药学会.pdf
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228762, encodeId=210c1228e6226, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e655505887, createdName=ms6000001815215928, createdTime=Sun Jun 26 13:00:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072187, encodeId=c0f110e2187ef, content=(、∴学𠃌刁习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:34:22 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072181, encodeId=ce1d10e218120, content=后什价值{彳得、∴学翔翔, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:15:23 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070804, encodeId=fbd910e08044c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83125648445, createdName=ms3000000834784203, createdTime=Tue Nov 16 16:05:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015856, encodeId=f6b71015856c3, content=<a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76828, encryptionId=62d2e6828cc, topicName=糖皮质激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed Sep 08 22:52:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2022-06-26 ms6000001815215928

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228762, encodeId=210c1228e6226, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e655505887, createdName=ms6000001815215928, createdTime=Sun Jun 26 13:00:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072187, encodeId=c0f110e2187ef, content=(、∴学𠃌刁习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:34:22 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072181, encodeId=ce1d10e218120, content=后什价值{彳得、∴学翔翔, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:15:23 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070804, encodeId=fbd910e08044c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83125648445, createdName=ms3000000834784203, createdTime=Tue Nov 16 16:05:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015856, encodeId=f6b71015856c3, content=<a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76828, encryptionId=62d2e6828cc, topicName=糖皮质激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed Sep 08 22:52:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-11-20 ms9000000080461052

    (、∴学𠃌刁习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1228762, encodeId=210c1228e6226, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e655505887, createdName=ms6000001815215928, createdTime=Sun Jun 26 13:00:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072187, encodeId=c0f110e2187ef, content=(、∴学𠃌刁习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:34:22 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072181, encodeId=ce1d10e218120, content=后什价值{彳得、∴学翔翔, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:15:23 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070804, encodeId=fbd910e08044c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83125648445, createdName=ms3000000834784203, createdTime=Tue Nov 16 16:05:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015856, encodeId=f6b71015856c3, content=<a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76828, encryptionId=62d2e6828cc, topicName=糖皮质激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed Sep 08 22:52:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-11-20 ms9000000080461052

    后什价值{彳得、∴学翔翔

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1228762, encodeId=210c1228e6226, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e655505887, createdName=ms6000001815215928, createdTime=Sun Jun 26 13:00:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072187, encodeId=c0f110e2187ef, content=(、∴学𠃌刁习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:34:22 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072181, encodeId=ce1d10e218120, content=后什价值{彳得、∴学翔翔, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:15:23 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070804, encodeId=fbd910e08044c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83125648445, createdName=ms3000000834784203, createdTime=Tue Nov 16 16:05:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015856, encodeId=f6b71015856c3, content=<a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76828, encryptionId=62d2e6828cc, topicName=糖皮质激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed Sep 08 22:52:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-11-16 ms3000000834784203

    值得学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1228762, encodeId=210c1228e6226, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e655505887, createdName=ms6000001815215928, createdTime=Sun Jun 26 13:00:25 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072187, encodeId=c0f110e2187ef, content=(、∴学𠃌刁习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:34:22 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072181, encodeId=ce1d10e218120, content=后什价值{彳得、∴学翔翔, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Sat Nov 20 12:15:23 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070804, encodeId=fbd910e08044c, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83125648445, createdName=ms3000000834784203, createdTime=Tue Nov 16 16:05:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015856, encodeId=f6b71015856c3, content=<a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76828, encryptionId=62d2e6828cc, topicName=糖皮质激素)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Wed Sep 08 22:52:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]

拓展阅读

2010 ACR 糖皮质激素相关骨质疏松防治指南

美国风湿病学会(ACR,American College of Rheumatology) · 2010-11-01

2011 糖皮质激素雾化吸入疗法在儿科应用的专家共识

中国儿科相关医学专家组(统称) · 2011-01-01

2011 糖皮质激素类药物临床应用指导原则

中华医学会(CMA,Chinese Medical Association) · 2011-02-15

肾上腺糖皮质激素在围术期应用的专家共识

中华医学会麻醉学分会 · 2012-12-20

2013 糖皮质激素诱导的骨质疏松诊治的专家共识

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2013-06-01

2013 EULAR循证建议:中等至大剂量糖皮质激素疗法治疗风湿性疾病

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2013-07-19